{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:08:40Z","timestamp":1789945720131,"version":"4.0.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012830","name":"Development and Reform Commission of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012830","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301357"],"award-info":[{"award-number":["81301357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371744"],"award-info":[{"award-number":["81371744"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773333"],"award-info":[{"award-number":["81773333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2013DFA3087"],"award-info":[{"award-number":["2013DFA3087"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"publisher","award":["20130162110073"],"award-info":[{"award-number":["20130162110073"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.037","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T07:29:43Z","timestamp":1536823783000},"page":"177-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis"],"prefix":"10.1016","volume":"108","author":[{"given":"Cuiling","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuotong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.09.037_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2018.09.037_bib0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2018.09.037_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"3","author":"Varga","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"10.1016\/j.biopha.2018.09.037_bib0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2018.09.037_bib0025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O\u2019Reilly","year":"2012","journal-title":"Rheumatol. Oxf. (Oxford)"},{"key":"10.1016\/j.biopha.2018.09.037_bib0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/BOR.0000000000000036","article-title":"T cell subsets and their role in the pathogenesis of rheumatic disease","volume":"26","author":"Gizinski","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1881","key":"10.1016\/j.biopha.2018.09.037_bib0035","article-title":"Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis","volume":"51","author":"Omoyinmi","year":"2012","journal-title":"Rheumatol. Oxf. (Oxford)"},{"key":"10.1016\/j.biopha.2018.09.037_bib0040","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.09.037_bib0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2018.09.037_bib0050","first-page":"765","article-title":"Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis","volume":"27","author":"Meloni","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0055","first-page":"1809","article-title":"Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis","volume":"35","author":"Antonelli","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0060","first-page":"834","article-title":"Elevation of serum lymphotactin levels in patients with systemic sclerosis","volume":"35","author":"Muroi","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0070","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","article-title":"Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model","volume":"185","author":"Yoshizaki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4049\/jimmunol.1301062","article-title":"EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis","volume":"192","author":"Zhang","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0080","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2741\/4054","article-title":"Poli V. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?","volume":"17","author":"Camporeale","year":"2012","journal-title":"Front. Biosci. Landmark Ed. (Landmark Ed)"},{"key":"10.1016\/j.biopha.2018.09.037_bib0085","first-page":"591","article-title":"Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells","volume":"138","author":"Singh","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.biopha.2018.09.037_bib0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1681\/ASN.2013080904","article-title":"Stat3 programs Th17-specific regulatory T cells to control GN","volume":"25","author":"Kluger","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.it.2011.06.007","article-title":"T helper 17 cell heterogeneity and pathogenicity in autoimmune disease","volume":"32","author":"Ghoreschi","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2012.00129","article-title":"TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic?","volume":"3","author":"Marwaha","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0105","first-page":"165","article-title":"New insights into the pathogenesis of cutaneous autoimmune disorders","volume":"26","author":"Chiricozzi","year":"2012","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2018.09.037_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2015.02.002","article-title":"The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis","volume":"74","author":"Paulissen","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2018.09.037_bib0115","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00296-010-1710-0","article-title":"The Th17\/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis","volume":"32","author":"Wang","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2018.09.037_bib0120","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1186\/ar4066","article-title":"Th17 expansion in granulomatosis with polyangiitis (Wegener\u2019s): the role of disease activity, immune regulation and therapy","volume":"14","author":"Wilde","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.09.037_bib0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2015.01.001","article-title":"The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels","volume":"164","author":"Babaloo","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2018.09.037_bib0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2011.05.006","article-title":"Complement and cytokine based therapeutic strategies in myasthenia gravis","volume":"37","author":"Tuzun","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2018.09.037_bib0135","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodriguez-Reyna","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2018.09.037_bib0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3899\/jrheum.080120","article-title":"Increased serum interleukin 23 in patients with systemic sclerosis","volume":"35","author":"Komura","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0145","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2018.09.037_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","article-title":"The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis","volume":"76","author":"Zhou","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0155","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.09.037_bib0160","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105008","article-title":"High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis","volume":"9","author":"Lonati","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0170","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2018.09.037_bib0175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","volume":"17","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.biopha.2018.09.037_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0185","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2018.09.037_bib0190","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cbin.10410","article-title":"IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice","volume":"39","author":"Lei","year":"2015","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.biopha.2018.09.037_bib0195","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.09.037_bib0200","doi-asserted-by":"crossref","first-page":"e85032","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0205","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl 100","key":"10.1016\/j.biopha.2018.09.037_bib0210","first-page":"14","article-title":"Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis","volume":"34","author":"Lei","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/path.4430","article-title":"IL-17A produced by both gammadelta T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction","volume":"235","author":"Peng","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0220","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0225","doi-asserted-by":"crossref","first-page":"e23185","DOI":"10.1371\/journal.pone.0023185","article-title":"IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis","volume":"6","author":"Gasse","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0230","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2018.09.037_bib0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clim.2013.10.001","article-title":"Th17 cell plays a role in the pathogenesis of Hashimoto\u2019s thyroiditis in patients","volume":"149","author":"Li","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0240","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxr001","article-title":"Recent advances in IL-22 biology","volume":"23","author":"Zenewicz","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0250","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.38136","article-title":"A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis","volume":"65","author":"Koumakis","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2018.09.037_bib0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2017.07.022","article-title":"IL-33-matured dendritic cells promote Th17 cell responses via IL-1beta and IL-6","volume":"99","author":"Park","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2018.09.037_bib0260","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4049\/jimmunol.1601890","article-title":"TLR7 signaling regulates Th17 cells and autoimmunity: novel potential for autoimmune therapy","volume":"199","author":"Ye","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4049\/jimmunol.1700457","article-title":"Regulation of Th17 differentiation by IKKalpha-dependent and -independent phosphorylation of RORgammat","volume":"199","author":"He","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/intimm\/dxt060","article-title":"Foxp3(+) T(reg) cells in humoral immunity","volume":"26","author":"Wing","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0275","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/rheumatology\/keq328","article-title":"FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells","volume":"50","author":"Abdulahad","year":"2011","journal-title":"Rheumatol. Oxf. (Oxford)"},{"key":"10.1016\/j.biopha.2018.09.037_bib0280","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2018.09.037_bib0285","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/eci.11.28","article-title":"CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases","volume":"7","author":"Michels-van","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/bmt.2013.202","article-title":"Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study","volume":"49","author":"Baraut","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.biopha.2018.09.037_bib0295","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2018.09.037_bib0300","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/823085","article-title":"Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0305","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2018.09.037_bib0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/03009742.2014.922214","article-title":"The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study","volume":"44","author":"Tselios","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.imlet.2015.04.006","article-title":"Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia","volume":"166","author":"Sollazzo","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2018.09.037_bib0320","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5603\/FHC.2011.0088","article-title":"Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus","volume":"49","author":"Kleczynska","year":"2011","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11926-013-0352-0","article-title":"Treg cells in rheumatoid arthritis: an update","volume":"15","author":"Cooles","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.biopha.2018.09.037_bib0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/1440-1681.12330","article-title":"Higher frequency of peripheral blood follicular regulatory T cells in patients with new onset ankylosing spondylitis","volume":"42","author":"Shan","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0335","doi-asserted-by":"crossref","first-page":"e56209","DOI":"10.1371\/journal.pone.0056209","article-title":"Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0340","doi-asserted-by":"crossref","first-page":"e5981","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0345","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0350","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/14397595.2014.899736","article-title":"Decreased expression of Runx1 and lowered proportion of Foxp3(+) CD25(+) CD4(+) regulatory T cells in systemic sclerosis","volume":"25","author":"Kataoka","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0355","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/jid.2009.313","article-title":"CD127(low\/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood","volume":"130","author":"Klein","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0360","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0365","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjd.12913","article-title":"DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis","volume":"171","author":"Wang","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0370","doi-asserted-by":"crossref","first-page":"e64531","DOI":"10.1371\/journal.pone.0064531","article-title":"Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2017.05.013","article-title":"Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis","author":"Ugor","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0380","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","article-title":"Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes","volume":"137","author":"Giovannetti","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0385","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","article-title":"Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease","volume":"204","author":"Sather","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.09.037_bib0390","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T cells reside in human skin","volume":"124","author":"Sanchez","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.09.037_bib0395","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2018.09.037_bib0400","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0405","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.09.037_bib0410","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0415","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.09.037_bib0420","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.coi.2009.03.001","article-title":"Transcriptional regulatory networks in Th17 cell differentiation","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0425","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coi.2009.05.021","article-title":"Developmental plasticity of Th17 and Treg cells","volume":"21","author":"Lee","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0430","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4161\/self.1.4.13946","article-title":"Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells","volume":"1","author":"Capurso","year":"2010","journal-title":"Self"},{"key":"10.1016\/j.biopha.2018.09.037_bib0435","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.09.037_bib0440","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.09.037_bib0450","doi-asserted-by":"crossref","first-page":"e1949","DOI":"10.7554\/eLife.01949","article-title":"T cell-intrinsic role of IL-6 signaling in primary and memory responses","volume":"3","author":"Nish","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2018.09.037_bib0455","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.09.037_bib0460","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2011.03.014","article-title":"Th17 and Treg balance in systemic sclerosis","volume":"139","author":"Khoury","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0465","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.09.037_bib0470","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.4049\/jimmunol.180.7.4785","article-title":"Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3","volume":"180","author":"Du","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0475","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.09.037_bib0480","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.09.037_bib0485","doi-asserted-by":"crossref","first-page":"e50909","DOI":"10.1371\/journal.pone.0050909","article-title":"The ratio of Treg\/Th17 cells correlates with the disease activity of primary immune thrombocytopenia","volume":"7","author":"Ji","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.09.037_bib0490","doi-asserted-by":"crossref","first-page":"247372","DOI":"10.1155\/2014\/247372","article-title":"Effect of Th17 and Treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases","volume":"2014","author":"Gaowa","year":"2014","journal-title":"Med. Inflamm."},{"key":"10.1016\/j.biopha.2018.09.037_bib0495","doi-asserted-by":"crossref","first-page":"e1003453","DOI":"10.1371\/journal.ppat.1003453","article-title":"The Th17\/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation","volume":"9","author":"Chevalier","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2018.09.037_bib0500","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1582-4934.2006.tb00538.x","article-title":"The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis","volume":"10","author":"Sfrent-Cornateanu","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2018.09.037_bib0505","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0510","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1700645","article-title":"Notch balances Th17 and induced regulatory t cell functions in dendritic cells by regulating Aldh1a2 expression","author":"Zaman","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0515","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature23475","article-title":"Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism","volume":"548","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.09.037_bib0520","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","article-title":"Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics","volume":"43","author":"van den Berg","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2018.09.037_bib0525","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0530","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-015-0555-7","article-title":"Cellular therapies in systemic sclerosis: recent progress","volume":"18","author":"van Rhijn-Brouwer","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.biopha.2018.09.037_bib0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2018.09.037_bib0540","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/imt.13.47","article-title":"Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?","volume":"5","author":"Tanaka","year":"2013","journal-title":"Immunother. UK"},{"key":"10.1016\/j.biopha.2018.09.037_bib0545","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clim.2011.09.014","article-title":"Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis","volume":"142","author":"Papp","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.037_bib0550","doi-asserted-by":"crossref","first-page":"e74722","DOI":"10.1371\/journal.pone.0074722","article-title":"Endurance exercise diverts the balance between Th17 cells and regulatory T cells","volume":"8","author":"Perry","year":"2013","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218348418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218348418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:42:57Z","timestamp":1777272177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218348418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":110,"alternative-id":["S0753332218348418"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.037","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}